Synchronous chemoradiation significantly reduces the risk of the breast cancer recurrence
20 Oct 2011
Synchronous chemoradiation significantly reduces the risk of the breast cancer recurrence
Recent advances in advanced breast cancer
Looking forward to the 2012 ESTRO meeting
Advances in the treatment of lung cancer and melanoma
Roundup of the EMCC 2011 conference
Improving pre-clinical experimental models to test anti cancer drugs
Changing drug discovery: share data
Ruxolitinib successfully treats myelofibrosis symptoms and improves quality of life
Key CLL research from EHA 2011
The changing landscape of melanoma therapies: indications of better patient outcome
Standard of care for ovarian cancer
Olaparib maintenance therapy for ovarian cancer and updates from ICON7